Raskob, Gary E <br/><br/>
Early time courses of recurrent thromboembolism and bleeding during apixaban or enoxaparin/warfarin therapy. A sub-analysis of the AMPLIFY trial.  [electronic resource] 

 -  Thrombosis and haemostasis  Apr 2016 
 - 809-16 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2567-689X 
<br/><br/><label>Standard No.: </label>10.1160/TH15-09-0752  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Enoxaparin--therapeutic use<br/>Female<br/>Follow-Up Studies<br/>Hemorrhage--epidemiology<br/>Humans<br/>Male<br/>Middle Aged<br/>Pyrazoles--therapeutic use<br/>Pyridones--therapeutic use<br/>Recurrence<br/>Risk<br/>Treatment Outcome<br/>Venous Thromboembolism--complications<br/>Warfarin--therapeutic use